The prognostic value of global myocardium strain by CMR-feature tracking in immune checkpoint inhibitor–associated myocarditis

[1]  R. Sullivan,et al.  Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis. , 2021, Journal of the American College of Cardiology.

[2]  D. Peters,et al.  Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity , 2021, PloS one.

[3]  A. Huber,et al.  Feature Tracking Myocardial Strain Incrementally Improves Prognostication in Myocarditis Beyond Traditional CMR Imaging Features. , 2020, JACC. Cardiovascular imaging.

[4]  A. Lyon,et al.  The Role of Biomarkers in Cardio-Oncology , 2020, Journal of Cardiovascular Translational Research.

[5]  Daniel C. Lee,et al.  Prognostic Value of Myocardial Extracellular Volume Fraction and T2-mapping in Heart Transplant Patients. , 2020, JACC. Cardiovascular imaging.

[6]  R. Sullivan,et al.  Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis. , 2020, European heart journal.

[7]  R. Sullivan,et al.  Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis. , 2020, Journal of the American College of Cardiology.

[8]  R. Kwong,et al.  Myocarditis in Athletes Is a Challenge: Diagnosis, Risk Stratification, and Uncertainties. , 2020, JACC. Cardiovascular imaging.

[9]  G. Barbati,et al.  Strain analysis reveals subtle systolic dysfunction in confirmed and suspected myocarditis with normal LVEF. A cardiac magnetic resonance study , 2019, Clinical Research in Cardiology.

[10]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. , 2018, Journal of the American College of Cardiology.

[11]  R. Kim,et al.  Feature-Tracking Global Longitudinal Strain Predicts Death in a Multicenter Population of Patients With Ischemic and Nonischemic Dilated Cardiomyopathy Incremental to Ejection Fraction and Late Gadolinium Enhancement. , 2018, JACC. Cardiovascular imaging.

[12]  H. Thiele,et al.  Cardiac Magnetic Resonance Myocardial Feature Tracking for Optimized Prediction of Cardiovascular Events Following Myocardial Infarction. , 2018, JACC. Cardiovascular imaging.

[13]  T. Neilan,et al.  Immune Checkpoint Inhibitor-Associated Myocarditis. , 2018, The oncologist.

[14]  G. Pontone,et al.  Cardiac MR With Late Gadolinium Enhancement in Acute Myocarditis With Preserved Systolic Function: ITAMY Study. , 2017, Journal of the American College of Cardiology.

[15]  Thor Edvardsen,et al.  Geometry as a Confounder When Assessing Ventricular Systolic Function: Comparison Between Ejection Fraction and Strain. , 2017, Journal of the American College of Cardiology.

[16]  J. Seidman,et al.  Fulminant Myocarditis with Combination Immune Checkpoint Blockade. , 2016, The New England journal of medicine.

[17]  K. Ohshima,et al.  Acute Lymphocytic Myocarditis With Anti-PD-1 Antibody Nivolumab. , 2016, Circulation. Heart failure.

[18]  G. Pedrizzetti,et al.  Principles of cardiovascular magnetic resonance feature tracking and echocardiographic speckle tracking for informed clinical use , 2016, Journal of Cardiovascular Magnetic Resonance.

[19]  J. Plana,et al.  The Utility of Point-of-Care Biomarkers to Detect Cardiotoxicity During Anthracycline Chemotherapy: A Feasibility Study. , 2016, Journal of cardiac failure.

[20]  Eric E. Smith,et al.  2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). , 2015, Circulation.

[21]  B. Schnackenburg,et al.  Performance of T1 and T2 Mapping Cardiovascular Magnetic Resonance to Detect Active Myocarditis in Patients With Recent-Onset Heart Failure , 2015, Circulation. Cardiovascular imaging.

[22]  M. Bossard,et al.  Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma , 2015, Journal of Immunotherapy for Cancer.

[23]  W. Stevenson,et al.  Late gadolinium enhancement among survivors of sudden cardiac arrest. , 2015, JACC. Cardiovascular imaging.

[24]  Eric E. Smith,et al.  2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). , 2015, Journal of the American College of Cardiology.

[25]  Petr Otahal,et al.  Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction , 2014, Heart.

[26]  Tiina Heliö,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[27]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[28]  E. Ricevuto,et al.  Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients , 2011, British Journal of Cancer.

[29]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[30]  Judith S. Hochman,et al.  Cardiogenic Shock: Current Concepts and Improving Outcomes , 2008, Circulation.

[31]  K R Hess,et al.  Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. , 1995, Statistics in medicine.

[32]  David A. Schoenfeld,et al.  Partial residuals for the proportional hazards regression model , 1982 .